EHC · Encompass Health Corporation
$121.71
+0.55% last session
End-of-day data · close of 2026-09-11
Market cap
$12B
Enterprise value
$16B
Trailing P/E
20.2
Forward P/E
18.1
Dividend yield
1.0%
Beta
0.61
Avg volume
1M
Employees
30K
Daily Change %
0.55%
5 Days Change
-0.22%
10 Days Change
1.09%
30 Days Change
-3.06%
60 Days Change
10.31%
Month to Day Change
-0.43%
Year to Day Change
15.14%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — EHC
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-08-10
Latest call per bank · past 12 months
UBS
Buy$155
+28.1% vs priceBarclays
Overweight$144
+19.0% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-08-10 | TD Cowen | Maintains | Buy | $125 → $140 |
| 2026-08-07 | UBS | Maintains | Buy | $150 → $155 |
| 2026-08-07 | Truist Securities | Maintains | Buy | $140 → $150 |
| 2026-08-06 | Barclays | Maintains | Overweight | $140 → $144 |
| 2026-05-28 | TD Cowen | Initiates | Buy | $0.00 → $125 |
| 2026-05-05 | Barclays | Maintains | Overweight | $153 → $140 |
| 2026-02-06 | Barclays | Maintains | Overweight | $150 → $153 |
| 2025-10-30 | Barclays | Maintains | Overweight | $141 → $150 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-09-11
- RSI (14): RSI is 56 — neutral momentum, neither overbought nor oversold.
- Price vs 50-day MA: Trading 4.2% above the 50-day MA ($116.86).
- Price vs 200-day MA: Trading 13.6% above the 200-day MA ($107.14).
- MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
- MACD (12,26,9): MACD histogram is negative (-0.40) — short-term momentum is fading.
- 52-week range: Price is within 5% of the 52-week high ($126.46).
EHC Price Chart
Loading chart for EHC…
Fundamentals
About Encompass Health Corporation
Encompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico. The company offers specialized rehabilitative treatment, using technology and therapy, on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability, independence, and quality of life; medical, nursing, therapy, and ancillary services; and rehabilitative care to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. It offers services through the Medicare program to the federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was incorporated in 1984 and is based in Birmingham, Alabama.
More in Medical Care Facilities
HCA
HCA Healthcare, Inc.
$93B -9.3% YTD
THC
Tenet Healthcare Corporation
$21B 35.4% YTD
FMS
Fresenius Medical Care AG
$12B -2.5% YTD
DVA
DaVita Inc.
$12B 61.1% YTD
UHS
Universal Health Services, Inc.
$10B -19.1% YTD
ENSG
The Ensign Group, Inc.
$10B -1.3% YTD
CHE
Chemed Corp
$7B 21.7% YTD
PACS
PACS Group, Inc.
$7B 16.2% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.